Skip to main content

USCAP eLearning

Events
Courses
Product Bundles
My Videos
Search
Cart 0
Sign In

Item Added to Cart

You just added

You have item(s) in your cart

  • Proceed to Checkout
  1. Courses
  2. Modern Pathology
  3. Implications of the Tumor I...

Implications of the Tumor Immune Microenvironment for Staging and Therapeutics - Robert A. Anders, MD, PhD



Original release date:
April 28, 2020
Access to this course expires on:  February 16, 2023 at 11:59 PM Pacific Time
CME 1

Faculty: Robert A. Anders, MD, PhD

Learning Objectives:
  1. Understand the value of the tumor immune microenvironment in cancer patient prognosis
  2. Discuss the use of microsatellite unstable (MSI HI) / mismatch repair deficiency testing in relation to immune based anti-cancer therapy.
  3. Gain knowledge of how newer immune based anti-cancer therapies will likely impact diagnostic pathology
  4. Explain the challenges in reporting PD-L1 immunohistochemical staining

$104.00 - $139.00
Member
$104.00
Non-Member
$139.00
Items Included in the Purchase of this Section

Implications of the tumor immune microenvironment for staging and therapeutics

Presentation: Robert A. Anders, MD, PhD, 58 min 2 sec

CME Survey: Implications of the tumor immune microenvironment for staging and therapeutics

Survey: 1.0 CME 15 questions

Implications of the tumor immune microenvironment

Certificate: 0/2 Course items completed

SAM Test: Implications of the tumor immune microenvironment for staging and therapeutics

Assessment: 4 questions Unlimited retakes on fail

PowerPoint Presentation

Document: Implications of the tumor immune microenvironment for staging and therapeutics
  • Events
  • Courses
  • Search
  • Support
  • USCAP.org
  • Sign In
  • Privacy Policy | Cookie Notice